Track when multi-billion dollar drug blockbusters lose patent exclusivity. Monitor Paragraph IV generic challenges and regulatory exclusivity expirations with sub-50ms latency.
$89.2B+
Revenue at Cliff (2026-2028)
100%
FDA Orange Book Normalized
Sub-50ms
Global Edge Query Latency
ANDA Ready
Paragraph IV Litigation Tracking
🔍 Search Drug Patents & Cliffs
Search by brand name, active molecule, sponsor, or therapeutic class
🛡️ Patent Suite & Regulatory Breakdown
Inspect compound (NCE), formulation, delivery device patents, and generic challengers
// Select a drug from the left panel to inspect its full patent suite...
🤖 Automated Pharma Intelligence (cURL / Python)
One-liner integration for market research, biotech investment bots, and generic pipeline trackers